Price Action, Analyst Forecasts, and What Investors Are Watching
Boston Scientific Corporation (NYSE: BSX) is back in the spotlight on Tuesday, December 16, 2025, as the stock trades in the low-$90s—well below its September highs—while Wall Street’s broader view remains notably upbeat on the medical-device leader’s growth outlook.
As of the latest available market data, BSX traded around $92.23 on Dec. 16, with an intraday range of roughly $90.44 to $92.77. That places the stock about 16% below its 52‑week high of $109.50 and roughly 7% above its 52‑week low of $85.98, highlighting how sharply sentiment has cooled since the late-summer peak even as fundamentals have stayed resilient. [1]
What changed today? The short version: a fresh price-target reset from Baird, ongoing institutional…
